Pfizer has notified Pain Therapeutics that it has decided to discontinue its agreement to develop and commercialize Remoxy (oxycodone) Extended-Release...
Pfizer Inc has. announced that the FDA has approved Duavee (conjugated oestrogens/bazedoxifene) 0.45mg / 20mg tablets, a novel therapy for...
In 2008, Catalyst Biosciences signed a $500 million-plus deal to develop Factor VIIa therapies for hemophilia with Pfizer. However Pfizer...
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal comprising £24.76 in cash (45%)...
Pfizer Inc. announced that the merger agreement between Pfizer and Allergan plc has been terminated by mutual agreement of the...
Pfizer Inc. and Hospira, Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire...
Pfizer Inc. announced that the European Commission (EC) has approved under the European Union (EU) Merger Regulation the company�s pending...
It is reported that Pfizer has offered �60 billion for AstraZeneca but that the approach was rejected. The aim of...
Pfizer Inc. and Allergan plc announced that their boards of directors have unanimously approved, and the companies have entered into,...
The FDA has accepted for review the New Drug Application (NDA) for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride), from Pfizer,...